Trulieve Cannabis Corp. (TRLV)

From the record

Trulieve Cannabis Corp.'s filings since 2018 show 3 warning events of 2 kinds: an auditor change (8-K item 4.01, 2 times, the latest 2024-03-29); a late-report notice (Form NT 10-K or NT 10-Q, the latest 2023-02-24) (its current reports).

From the record

Trulieve Cannabis Corp.'s 7 filed years say what it did: revenue went from $253 million in fiscal 2019 to $1.2 billion in fiscal 2025, up 29.3% a year; it rose in 4 of 6 years; the deepest fall was 7% from fiscal 2022 to fiscal 2023; net income was positive in 3 of 7 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Trulieve Cannabis Corp.'s diluted share count grew about 0.6% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 7 sales (7 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Trulieve Cannabis Corp. lost about 11 cents for every dollar of shareholders' money, and gross profitability: its products earned about 26 cents per dollar of everything the company owns. Leverage: it owed about 58 cents per dollar of assets, and net share issuance: its share count grew 0.7% over the year (the filed statements).

From the record

Trulieve Cannabis Corp.'s standing among 18 graded names in its industry family: revenue of $1.2 billion in fiscal 2025 ranks in the top 4% by size; a net margin of -10.3% ranks in the top 42%; revenue growth of -1% a year over the last 3 filed years ranks in the bottom 42% (its annual reports).

From the record

Trulieve Cannabis Corp.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Rivers, Kim A. (Chairman and CEO, as filed), filing under that title since 2021-02-04, 5.8 years (top 25% of its family); the 19 officers and directors filing in the last fifteen months have been on the record a median of 5.1 years (top 50%); 12 officer or director changes were reported on Form 8-K since 2023-11-13, against the 19 people in charge now (bottom 46%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Trulieve Cannabis Corp.'s room to grow, from the newest filed statements (fiscal 2025): cash of $256 million against debt of $137 million leaves 4.4% of its assets as net cash, bottom 24% of its family; cash from operations less capital spending is 19.4% of revenue (top 3%); a gross margin of 60.2% (top 26%) (its annual report).

From the record

Trulieve Cannabis Corp.'s growth drivers, from the filed years to fiscal 2025: revenue grew -1% a year over the last three filed years against 29.3% over all 7, slowing (bottom 36% of its family); the newest year grew -0.4% (bottom 36%); capital spending grew -35.5% a year (bottom 15%) (its annual reports). Trulieve Cannabis Corp. reported 2 product lines in fiscal 2025: Retail at $1.1 billion (94%), Wholesale and Other at $71 million (6%); 1 of 2 grew against the year before (its annual report).

From the record

Trulieve Cannabis Corp.'s newest year against its own record: revenue of $1.2 billion in fiscal 2025 came in 0.9% above the $1.2 billion its prior three years' pace pointed to (top 42% of its family); net income of $122 million against a prior three-year average of $315 million (bottom 47%); a net margin of -10.3% against -27.2% before (bottom 47%) (its annual reports).